Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease

Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease

Bibliographic Details
Main Authors:	Shane V Hegarty, Aideen M Sullivan, Gerard W O'Keeffe
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2017-01-01
Series:	Neural Regeneration Research
Online Access:	http://www.nrronline.org/article.asp?issn=1673-5374;year=2017;volume=12;issue=11;spage=1814;epage=1815;aulast=Hegarty

Similar Items

Wnt5a regulates midbrain dopaminergic axon growth and guidance.
by: Brette D Blakely, et al.
Published: (2011-03-01)

Sonic hedgehog is a chemoattractant for midbrain dopaminergic axons.
by: Rachel Hammond, et al.
Published: (2009-09-01)

Visualization of dopaminergic midbrain structures in Parkinson’s disease
by: R. R. Bogdanov, et al.
Published: (2017-02-01)

Gene Co-expression Analysis Identifies Histone Deacetylase 5 and 9 Expression in Midbrain Dopamine Neurons and as Regulators of Neurite Growth via Bone Morphogenetic Protein Signaling
by: Martina Mazzocchi, et al.
Published: (2019-09-01)

Ascending Midbrain Dopaminergic Axons Require Descending GAD65 Axon Fascicles for Normal Pathfinding
by: Claudia Marcela Garcia-Peña, et al.
Published: (2014-06-01)

Biophysical Properties of Somatic and Axonal Voltage-Gated Sodium Channels in Midbrain Dopaminergic Neurons
by: Jun Yang, et al.
Published: (2019-07-01)

Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease
by: Domingo Afonso-Oramas, et al.
Published: (2009-12-01)

The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease
by: Susan R Goulding, et al.
Published: (2020-01-01)

Neurotrophic factor therapy for Parkinson′s disease: past, present and future
by: Aideen M Sullivan, et al.
Published: (2016-01-01)

Dkk1 regulates ventral midbrain dopaminergic differentiation and morphogenesis.
by: Diogo Ribeiro, et al.
Published: (2011-02-01)

Cholinergic modulation of midbrain dopaminergic systems.
by: Mena-Segovia, J, et al.
Published: (2008)

Acquisition of the Midbrain Dopaminergic Neuronal Identity
by: Simone Mesman, et al.
Published: (2020-06-01)

Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson’s disease in midbrain dopaminergic neurons
by: Gurvir S. Virdi, et al.
Published: (2022-11-01)

Parkinson's disease candidate gene prioritization based on expression profile of midbrain dopaminergic neurons
by: Vahedi Shahrooz, et al.
Published: (2010-08-01)

The transcription factor BCL11A defines distinct subsets of midbrain dopaminergic neurons
by: Marianna Tolve, et al.
Published: (2021-09-01)

Rhythmic oscillations in the midbrain dopaminergic nuclei in mice
by: Virginie J. Oberto, et al.
Published: (2023-06-01)

Srebf1 Controls Midbrain Dopaminergic Neurogenesis
by: Enrique M. Toledo, et al.
Published: (2020-05-01)

The Crucial Roles of Pitx3 in Midbrain Dopaminergic Neuron Development and Parkinson’s Disease-Associated Neurodegeneration
by: Xin Wang, et al.
Published: (2023-05-01)

The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease
by: Georgia Minakaki, et al.
Published: (2020-12-01)

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson’s disease
by: Susan R Goulding, et al.
Published: (2022-01-01)

Maintenance of mitochondrial integrity in midbrain dopaminergic neurons governed by a conserved developmental transcription factor
by: Federico Miozzo, et al.
Published: (2022-03-01)

Disrupted functional connectivity with dopaminergic midbrain in cocaine abusers.
by: Dardo Tomasi, et al.
Published: (2010-05-01)

Analysis of individual differences in neurofeedback training illuminates successful self-regulation of the dopaminergic midbrain
by: Lydia Hellrung, et al.
Published: (2022-08-01)

The transcription factor Uncx4.1 acts in a short window of midbrain dopaminergic neuron differentiation
by: Rabe Tamara I, et al.
Published: (2012-12-01)

Human midbrain dopaminergic neuronal differentiation markers predict cell therapy outcomes in a Parkinson’s disease model
by: Peibo Xu, et al.
Published: (2022-07-01)

Structural correlates of heterogeneous in vivo activity of midbrain dopaminergic neurons
by: Henny, P, et al.
Published: (2012)

Structural correlates of heterogeneous in vivo activity of midbrain dopaminergic neurons.
by: Henny, P, et al.
Published: (2012)

Development and differentiation of midbrain dopaminergic neuron: from bench to bedside
by: Wang, Mengmeng, et al.
Published: (2020)

Identifying secreted biomarkers of dopaminergic ventral midbrain progenitor cells
by: Pedro Rifes, et al.
Published: (2023-12-01)

Chronic–Progressive Dopaminergic Deficiency Does Not Induce Midbrain Neurogenesis
by: Mareike Fauser, et al.
Published: (2021-03-01)

Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside
by: Mengmeng Wang, et al.
Published: (2020-06-01)

MOLECULAR HETEROGENEITY OF NON-HUMAN PRIMATE MIDBRAIN DOPAMINERGIC NEURONS.
by: Nagore Hernández Pinedo, et al.
Published: (2023-10-01)

En1 and Wnt signaling in midbrain dopaminergic neuronal development
by: Smidt Marten P, et al.
Published: (2011-05-01)

The Shh coreceptor Cdo is required for differentiation of midbrain dopaminergic neurons
by: Yu-Rim Kwon, et al.
Published: (2014-09-01)

Interaction of NMDA receptor and pacemaking mechanisms in the midbrain dopaminergic neuron.
by: Joon Ha, et al.
Published: (2013-01-01)

Regulation of Adult CNS Axonal Regeneration by the Post-transcriptional Regulator Cpeb1
by: Wilson Pak-Kin Lou, et al.
Published: (2018-01-01)

Lewy Body-like Pathology and Loss of Dopaminergic Neurons in Midbrain Organoids Derived from Familial Parkinson’s Disease Patient
by: Andrea Becerra-Calixto, et al.
Published: (2023-02-01)

Transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson′s disease?
by: Björn Spittau
Published: (2015-01-01)

Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson’s disease: removing axonal debris
by: Ingrid Morales, et al.
Published: (2021-11-01)

The Influence of Prenatal Exposure to Methamphetamine on the Development of Dopaminergic Neurons in the Ventral Midbrain
by: Walaa F. Alsanie, et al.
Published: (2023-03-01)